LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

CVS Health Corp.

Suletud

SektorTervishoid

77.86 -1.93

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

77.8

Max

78.58

Põhinäitajad

By Trading Economics

Sissetulek

-3.8B

-2.8B

Müük

4B

103B

P/E

Sektori keskmine

204.053

105.69

Aktsiakasum

1.6

Dividenditootlus

3.37

Kasumimarginaal

-2.722

Töötajad

219,000

EBITDA

-4B

-1.6B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+14.78% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.37%

2.37%

Turustatistika

By TradingEconomics

Turukapital

-6.1B

98B

Eelmine avamishind

79.79

Eelmine sulgemishind

77.86

Uudiste sentiment

By Acuity

64%

36%

309 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

CVS Health Corp. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. okt 2025, 10:48 UTC

Tulu

CVS Posts Loss on Write-Down, Boosts Guidance as Adjusted Earnings Rise

30. okt 2025, 20:45 UTC

Tulu

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

30. okt 2025, 20:30 UTC

Tulu

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

30. okt 2025, 14:52 UTC

Tulu

Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services -- Barrons.com

30. okt 2025, 10:21 UTC

Tulu

Cigna Beats Earnings Expectations. The Stock Is Facing Political Uncertainties. -- Barrons.com

29. okt 2025, 20:14 UTC

Tulu

Why CVS Buying Oak Street Health in 2023 Was One of Worst Healthcare Deals in Recent Years -- Barrons.com

29. okt 2025, 16:00 UTC

Tulu

In Medicare, Less Is Now More for Big Insurers -- Heard on the Street -- WSJ

29. okt 2025, 13:31 UTC

Tulu

CVS Posts Loss on Write-Down, Boosts Guidance -- Update

29. okt 2025, 11:13 UTC

Tulu

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

29. okt 2025, 10:46 UTC

Tulu

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

29. okt 2025, 10:30 UTC

Tulu

CVS Health Raises 2025 View To Adj EPS $6.55-Adj EPS $6.65 >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Adjusted Operating Income $3.46B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health Now Sees 2025 Cash Flow From Operations $7.5B-$8B; Had Seen at Least $7.5B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health Posts 3Q $5.7B Goodwill Impairment Charge Related to Healthcare Delivery Unit >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Front Store Same-Store Sales Up 1.5% >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Healthcare Benefits Segment Revenue $35.99B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Health Services Segment Revenue $49.27B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Same-Store Sales Up 14.3% >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue $36.21B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue Up 11.7% >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Pharmacy Same-Store Sales Up 16.8% >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Rev $102.87B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Loss $3.98B >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health Sees FY Loss/Shr 34c-Loss 24c >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Healthcare Benefits Segment Revenue Up 9.1% >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health Sees FY Adj EPS $6.55-Adj EPS $6.65 >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Loss/Shr $3.13 >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health Sees FY Loss $432M-Loss $307M >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Adj EPS $1.60 >CVS

29. okt 2025, 10:30 UTC

Tulu

CVS Health 3Q Health Services Segment Revenue Up 11.6% >CVS

Võrdlus sarnastega

Hinnamuutus

CVS Health Corp. Prognoos

Hinnasiht

By TipRanks

14.78% tõus

12 kuu keskmine prognoos

Keskmine 89.31 USD  14.78%

Kõrge 102 USD

Madal 75 USD

Põhineb 17 Wall Streeti analüütiku instrumendi CVS Health Corp. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

17 ratings

16

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

65.92 / 68.28Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

309 / 374 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
help-icon Live chat